Activation of c-Src/HER1/STAT5b and HER1/ERK1/2 signaling pathways and cell migration by hexachlorobenzene in MDA-MB-231 human breast cancer cell line

Toxicological Sciences

Volumn 120, Issue 2, 2011, Pages 284-296

  Pontillo, Carolina A ^a   García, María A ^a   Peña, Delfina ^a   Cocca, Claudia ^a   Chiappini, Florencia ^a   Alvarez, Laura ^a   de Pisarev, Diana Kleiman ^a   Randi, Andrea S ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

AhR; C Src; Cell migration; HER1; Hexachlorobenzene; MDA MB 231

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HEXACHLOROBENZENE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN HER1; PROTEIN KINASE P60; STAT5B PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; SIGNAL TRANSDUCTION;

RATTUS;

EID: 79953116194     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfq390     Document Type: Article

References (42)

1. Alvarez, L., Randi, A., Alvarez, P., Piroli, G., Chamson-Reig, A., Lux-Lantos, V., and Kleiman de Pisarev, D. (2000). Reproductive effects of hexachlorobenzene in female rats. J. Appl. Toxicol. 20, 81-87.
2. Agency for Toxic Substances and Disease Registry (ATSDR). (2002). Toxicological Profile for Hexachlorobenzene. U.S.D.O.H.A.H., Services, Atlanta, GA.
3. Barouki, R., Coumoul, X., and Fernandez-Salguero, P. M. (2007). The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein. FEBS Lett. 581, 3608-3615.
4. Bartucci, M., Morelli, C., Mauro, L., Andó, S., and Surmacz, E. (2001). Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Cancer Res. 61, 6747-6754.
5. Bernaciak, T. M., Zareno, J., Parsons, J. T., and y Silva, C. M. (2009).Anovel role for signal transducer and activator of transcription 5b (STAT5b) in b1-integrin-mediated human breast cancer cell migration. Breast Cancer Res. 11, 1-11.
6. Biscardi, J. S.,Maa,M. C., Tice, D. A., Cox,M. E., Leu, T. H., and Parsons, S. J. (1999). c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J. Biol. Chem. 274, 8335-8343.
7. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
8. Bulayeva, N. N., and Watson, C. S. (2004). Xenoestrogen-induced ERK1 and ERK-2 activation via multiple membrane-initiated signaling pathways. Environ. Health Perspect. 112, 1481-1487.
9. Chen, J. X., Zeng, H., Tuo, Q. H., Yu, H., Meyrick, B., and Aschner, J. L. (2007). NADPH oxidase modulates myocardial Akt, ERK1/2 activation, and angiogenesis after hypoxia-reoxygenation. Am. J. Physiol. Heart Circ. Physiol. 292, 1664-1674.
10. Dimri, M., Naramura, M., Duan, L., Chen, J., Ortega-Cava, C., Chen, G., Goswami, R., Fernandes, N., Gao, Q., Dimri, G. P., et al. (2007). Modeling breast cancer-associated c-Src and EGFR overexpression in human MECs: c-Src and EGFR cooperatively promote aberrant threedimensional acinar structure and invasive behavior. Cancer Res. 67, 4164-4172.
11. Diry, M., Tomkiewicz, C., Koehle, C., Coumoul, X., Bock, K. W., Barouki, R., and Transy, C. (2006). Activation of the dioxin/aryl hydrocarbon receptor (AhR) modulates cell plasticity through a JNK-dependent mechanism. Oncogene 25, 5570-5574.
12. Ezendam, J., Vissers, I., Bleumink, R., Vos, J. G., and Pieters, R. (2003). Immunomodulatory effects of tetrachlorobenzoquinone, a reactive metabolite of hexachlorobenzene. Chem. Res. Toxicol. 16, 688-694.
13. Frame, M. C. (2002). Src in cancer: deregulation and consequences for cell behaviour. Biochim. Biophys. 1602, 114-130.
14. García, M. A., Peña, D., Alvarez, L., Cocca, C., Pontillo, C., Bergoc, R., Kleiman de Pisarev, D. L., and Randi, A. (2010). Hexachlorobenzene induces cell proliferation and IGF-I signaling pathway in an estrogen receptor alpha-dependent manner in MCF-7 breast cancer cell line. Toxicol. Lett. 192, 195-205.
15. Haarmann-Stemmann, T., Hanno, B., and Josef, A. (2009). Growth factors, cytokines and their receptors as downstream targets of aryl hydrocarbon receptor (AhR) signaling pathways. Biochem. Pharmacol. 77, 508-520.
16. Hahn, M. E., Goldstein, J. A., Linko, P., and Gasiewicz, T. A. (1989). Interaction of hexachlorobenzene with the receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in vitro and in vivo. Arch. Biochem. Biophys. 270, 344-355.
17. Kleiman de Pisarev, D. L., Rios de Molina, M. C., and San Martin de Viale, L. C. (1990). Thyroid function and thyroxine metabolism in hexachlorobenzeneinduced porphyria. Biochem. Pharmacol. 39, 817-825.
18. Kloth, M. T., Laughlin, K. K., Biscardi, J. S., Boerner, J. L., Parsons, S. J., and Silva, C. M. (2003). STAT5b, a mediator of synergism between c-Src and the epidermal growth factor receptor. J. Biol. Chem. 278, 1671-1679.
19. Kohle, C., Gschaidmeier, H., Lauth, D., Topell, S., Zitzer, H., and Bock, K. W. (1999). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-mediated membrane translocation of c-Src protein kinase in liver WB-F344 cells. Arch. Toxicol. 73, 152-158.
20. Koppikar, P., Choi, S. H., Egloff, A. M., Cai, Q., Suzuki, S., Freilino, M., Nozawa, H., Thomas, S. M., Gooding, W. E., Siegfried, J. M., et al. (2008). Constitutive activation of signal transducer and activator of transcription 5 contributes to tumor growth, epithelial-mesenchymal transition, and resistance to epidermal growth factor receptor targeting. Clin. Cancer Res. 23, 7682-7690.
21. Lin, P. H., Lin, C. H., Huang, C. C., Chuang, M. C., and Lin, P. (2007). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces oxidative stress, DNA strand breaks, and poly(ADP-ribose) polymerase-1 activation in human breast carcinoma cell lines. Toxicol. Lett. 172, 146-158.
22. Mahon, M. J., and Gasiewicz, A. T. (1992). Chelatable metal ions are not required for aryl hydrocarbon receptor transformation to a DNA binding form: phenanthrolines are possible competitive antagonists of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch. Biochem. Biophys. 297, 1-8.
23. Matsumura, F. (1994). How important is the protein phosphorylation pathway in the toxic expression of dioxin-type chemicals? Biochem. Pharmacol. 48, 215-224.
24. Merchant, M., Arellano, L., and Safe, S. (1990). The mechanism of action of alpha-naphthoflavone as an inhibitor of 2,3,7,8-tetrachlorodibenzo-p-dioxininduced CYP1A1 gene expression. Arch. Biochem. Biophys. 281, 84-89.
25. Miller, M. E., Holloway, A. C., and Foster, W. G. (2005). Benzo-[a]-pyrene increases invasion in MDA-MB-231 breast cancer cells via increased COX-II expression and prostaglandin E2 (PGE2) output. Clin. Exp. Metastasis 22, 149-156.
26. Mylchreest, E., and Charbonneau, M. (1997). Studies on the mechanism of uroporphyrinogen decarboxylase inhibition in hexachlorobenzene-induced porphyria in the female rat. Toxicol. Appl. Pharmacol. 145, 23-33.
27. Ou, Y. C., Conolly, R. B., Thomas, R. S., Xu, Y., Andersen, M. E., Chubb, L. S., Pitot, H. C., and Yang, R. S. (2001). A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay. Cancer Res. 61, 1879-1889.
28. Park, S., Dong, B., and Matsumura, F. (2007). Rapid activation of c-Src kinase by dioxin is mediated by the Cdc37-HSP90 complex as part of Ah receptor signaling in MCF10A cells. Biochemistry 46, 899-908.
29. Park, S., Mazina, O., Kitagawa, A., Wong, P., and Matsumura, F. (2004). TCDD causes suppression of growth and differentiation of MCF10A, human mammary epithelial cells by interfering with their insulin receptor signaling through c-Src kinase and ERK activation. J. Biochem. Mol. Toxicol. 18, 322-331.
30. Parsons, S. J., and Parsons, J. T. (2004). Src family kinases, key regulators of signal transduction. Oncogene 23, 7906-7909.
31. Plante, I., Charbonneau, M., and Cyr, D. G. (2002). Decreased gap junctional intercellular communication in hexachlorobenzene-induced gender-specific hepatic tumor formation in the rat. Carcinogenesis 23, 1243-1249.
32. Plante, I., Cyr, D. G., and Charbonneau, M. (2005). Involvement of the integrinlinked kinase pathway in hexachlorobenzene-induced gender-specific rat hepatocarcinogenesis. Toxicol. Sci. 88, 346-357.
33. Qin, H., Shao, Q., Curtis, H., Galipeau, J., Belliveau, D. J., Wang, T., Alaoui-Jamali, M. A., and Laird, D. W. (2002). Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication. J. Biol. Chem. 277, 29132-29138.
34. Randi, A. S., Cocca, C., Carbone, V., Nuñez, M., Croci, M., Gutierrez, A., Bergoc, R., and Kleiman de Pisarev, D. L. (2006). Hexachlorobenzene is a tumor co-carcinogen and induces alterations in insulin growth factors signaling pathway in the rat mammary gland. Toxicol. Sci. 89, 83-92.
35. Randi, A. S., Sanchez, M. S., Alvarez, L., Cardozo, J., Pontillo, C., and Kleiman de Pisarev, D. (2008). Hexachlorobenzene triggers AhR translocation to the nucleus, c-Src activation and EGFR transactivation in rat liver. Toxicol. Lett. 177, 116-122.
36. Rho, O., Kim, D. J., Kiguchi, K., and DiGiovanni, J. (2010). Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis. Mol. Carcinog. Advance Access published on July 20, 2010; doi: 10.1002/mc.20665.
37. Tice, D. A., Biscardi, J. S., Nickles, A. L., and Parsons, S. J. (1999). Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proc. Natl. Acad. Sci. U.S.A. 96, 1415-1420.
38. To-Figueras, J., Sala, M., Otero, R., Barrot, C., Santiago-Silva, M., Rodamilans, M., Herrero, C., Grimalt, J., and Sunyer, J. (1997). Metabolism of hexachlorobenzene in humans: association between serum levels and urinary metabolites in a highly exposed population. Environ. Health Perspect. 105, 78-83.
39. Toker, A., and Yoeli-Lerner, M. (2006). Akt signaling and cancer: surviving but not moving on. Cancer Res. 66, 3963-3966.
40. Verner, M. A., Charbonneau, M., López-Carrillo, L., and Haddad, S. (2008). Physiologically based pharmacokinetic modeling of persistent organic pollutants for lifetime exposure assessment: a new tool in breast cancer epidemiologic studies. Environ. Health Perspect. 116, 886-892.
41. Wang, C., Navab, R., Iakovlev, V., Leng, Y., Zhang, J., Tsao, M. S., Siminovitch, K., McCready, D. R., and Done, S. J. (2007). Abelson interactor protein-1 positively regulates breast cancer cell proliferation, migration, and invasion. Mol. Cancer Res. 5, 1031-1039.
42. Yoeli-Lerner, M., Yiu, G. K., Rabinovitz, I., Erhardt, P., Jauliac, S., and Toker, A. (2005). Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol. Cell 20, 539-550.